News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ashton-Rickardt Philip
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Disposed/sold 8,845 options to buy
@ $0.75, valued at
$6.6k
|
|
| 03/01/2023 |
4
| Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $1.09, valued at
$125.4k
|
|
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $3.03, valued at
$272.7k
|
|
| 07/02/2021 |
4
| Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $10.61, valued at
$954.9k
|
|
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|